＜＜Back

Next＞＞

Vol. 26　No. 4　1998

* With abstract in English

---

Guideline for phase I study on new anticancer drug

M. Shimoyama, et al.

Jpn Pharmacol Ther 1998 26(4) 441-54

Analgesic property of bisphosphonate, etidronate in animal models

F. Nishikaku, et al.

Jpn Pharmacol Ther 1998 26(4) 457-63*

---

Accelerating mechanisms of Marzulene-S in ulcer healing (1)
－Effects on angiogenesis and bFGF activity in chronic gastriculcer model－

K. Hayashi, et al.

Jpn Pharmacol Ther 1998 26(4) 465-73

---

Accelerating mechanisms of Marzulene-S in ulcer healing (2)
－Inhibitory effects of Marzulene-S on the adhesion of Helicobacter pylori to gastric mucosa, mononuclear cells migration and cytokine production－

K. Hayashi, et al.

Jpn Pharmacol Ther 1998 26(4) 475-9

---

Effect of Marzulene-S on the activities of human liver drug metabolizing enzymes, cytochrome P450

M. Sato, et al.

Jpn Pharmacol Ther 1998 26(4) 481-4

---

Metabolic fate of TAT-59 (1st report)
－Absorption, distribution, excretion and transfer to fetus and milk of ¹⁴C-TAT-59 after oral administration to rats－

M. Yoshida, et al.

Jpn Pharmacol Ther 1998 26(4) 485-509*

---

Metabolic fate of TAT-59 (2nd report)
－Identification of metabolites and metabolic pathways of TAT-59－

E. Matsushima, et al.

Jpn Pharmacol Ther 1998 26(4) 511-23*

---

Study of polaprezinc affect the pancreas

Y. Mera, et al.

Jpn Pharmacol Ther 1998 26(4) 525-36

---

Effects of recombinant human growth hormone (r-hGH) on somatic growth and kidney in 5/6 nephrectomized ratsl?

M. Kanai, et al.

Jpn Pharmacol Ther 1998 26(4) 537-49*

Phase I study of CR1505 (loxiglumide) , CCK receptor antagonist(1)
－A single intravenous infusion study－

R. Kato, et al.

Jpn Pharmacol Ther 1998 26(4) 551-563

---

Phase I study of CR1505 (loxiglumide) , CCK receptor antagonist(2)
－A multiple intravenous infusion study－

R. Kato, et al.

Jpn Pharmacol Ther 1998 26(4) 565-76

---

Pharmacokinetics and safety evaluation of 1% nadifloxacin lotion after topical application in healthy volunteers

A. Yura, et al.

Jpn Pharmacol Ther 1998 26(4) 577-87

Acute gastric mucosal lesions in patients during NSAID suppositories treatment

A. Maeda, et al.

Jpn Pharmacol Ther 1998 26(4) 589-95**

---

Study on the usefulness of MGV-5 (Niflec, oral lavage solution) in preparation　for colonoscopy when administered on the day before colonoscopy

K. Miki, et al.

Jpn Pharmacol Ther 1998 26(4) 597-610

---

Clinical results of new-combination analgesic agent (FY-750) in treatment of several pains

K. Tsuchimoto, et al.

Jpn Pharmacol Ther 1998 26(4) 611-8

---

Clinical evaluation of isopropylantipyrine and ibuprofen contained analgesic agent FY-750 in treatment for various pains

J. Nishida

Jpn Pharmacol Ther 1998 26(4) 619-25

---

Clinical trials of FY-750 combined ibuprofen and isopropylantipyrine for headache or menstrual pain

S. Nagata

Jpn Pharmacol Ther 1998 26(4) 627-33

---

Evaluation of bio‐actifis α/Y slimmingl agent (Lipofactor^TM)

R. Ishii, et al.

Jpn Pharmacol Ther 1998 26(4) 635-40